So, now what? what are the risks of breast cancer and myocardial infarction among women receiving hormonal replacement therapy after menopause?
نویسندگان
چکیده
1 Assistant Professor, Medical School, Santa Casa de São Paulo; Head of the Mastology Clinic, Santa Casa de São Paulo, São Paulo, SP, Brazil 2 Full Professor, Medical School, Santa Casa de São Paulo; Head of the Gynecologic and Menopause Endocrinology Clinic, Santa Casa de São Paulo, São Paulo, SP, Brazil 3 Professor, Medical School, Universidade de São Paulo, Instituto do Coração, São Paulo, SP, Brazil
منابع مشابه
[Hormonal replacement therapy and breast cancer].
The recent publication of some randomised control trials results and of two important cohort studies makes possible a better understanding of the relation between hormonal replacement therapy (HRT) and breast cancer. It is now well established that estrogen-progestin replacement therapy is associated with an elevation of breast cancer risk. It is not possible to define duration of treatment wit...
متن کاملTreatment of estrogen deficiency symptoms in women surviving breast cancer. Part 2: Hormone replacement therapy and breast cancer.
There are several million breast cancer survivors worldwide. In the United States, 180,000 women were diagnosed with breast cancer in 1997, and approximately 97,000 of these women have an extremely low chance of suffering a recurrence of their cancer. With an average age at diagnosis of 60 years and a 25-year expected duration of survival, the current number of breast cancer survivors in the Un...
متن کاملPnm-4: Role of Hormonal Factors and Use ofContraceptive Pills on Breast Cancer
Background: Large part of research related to reInternational Journal of Fertility & Sterility (IJFS), Vol 4, Suppl 1, Summer 2010 94 productivefactors in breast cancer risk before and after menopause, a study case - control is that it factors in deliberate and spontaneous abortion in the two groups of women with breast cancer (cases) and non-infected women (control group) study, described odds...
متن کاملBreast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
BACKGROUND Although breast cancer risk is greater in users of estrogen-progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. METHODS A total of 1,129,025 postmenopausal UK women provided prospective information on hormonal therap...
متن کاملEstrogen replacement therapy in patients with early breast cancer.
OBJECTIVE Most physicians believe that estrogen replacement therapy is contraindicated once a patient is diagnosed with breast cancer. Recently, several studies have shown that estrogen replacement therapy may be safely used in patients with early breast cancer that has been treated successfully. These women can have severe menopausal symptoms and are at risk for osteoporosis. We reviewed the c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Revista da Associacao Medica Brasileira
دوره 57 4 شماره
صفحات -
تاریخ انتشار 2011